Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Leukemia risk after maternal contraception use

Hargreave M et al. Lancet Oncol. 2018 Sep 6. doi: 10.1016/S1470-2045(18)30479-0

Key clinical point: Recent hormonal contraceptive use may slightly increase risk for certain leukemias in offspring.

Major finding: Recent maternal hormonal contraceptive use was linked to one additional case of leukemia per 47,170 children.

Study details: Danish nationwide cohort study in 1,185,157 children.

Disclosures: The study was supported by the Danish Cancer Research Foundation and other foundations. One author reported grants from the sponsoring foundations and another author reported speaking fees from Jazz Pharmaceuticals and Shire Pharmaceuticals

Read article here.

Citation:

Hargreave M et al. Lancet Oncol. 2018 Sep 6. doi: 10.1016/S1470-2045(18)30479-0.

Commentary:

Estrogenic compounds could have a number of effects on the genomic machinery, that could in turn lead to an increased risk of leukemia in offspring. It may be that oral contraceptives cause epigenetic changes to fetal hematopoietic stem cells that lead to gene rearrangements and oxidative damage, which could then influence the risk of developing childhood leukemia.

This study opens a new avenue of investigation for a risk factor that might increase a child’s susceptibility to leukemia and is important in shedding more light on dose-response associations of exposures.

Dr. Maria S. Pombo-de-Oliveira is from the pediatric hematology-oncology research program at the Instituto Nacional de Câncer in Rio de Janeiro. These comments are adapted from an accompanying editorial (Lancet Oncol. 2018 Sep 6. doi: 10.1016/S1470-2045[18]30509-6). Dr. Pombo-de-Oliveira reported having no conflicts of interest.

This Week's Must Reads

ACOG: Well-Women Visits Can Minimize Health Risks, Obstet Gynecol; 2018 Oct; ACOG, et al

Gender Images & Social Expectations in BC Diagnosis, Cancer; ePub 2018 Sep 24; Kim, Glassgow, et al

Intended Pregnancy After Being Denied an Abortion, Contraception; ePub 2018 Sep 20; Upadhyay, et al

Opioid Prescribing After Surgery for Pelvic Organ Prolapse, Female Pelvic Med Reconstr Surg; ePub 2018 Sep 22; Leach, et al

VTE risk for continuous cycle oral contraceptives, Li J et al. JAMA Intern Med. 2018 Oct 1. doi:10.1001/jamainternmed.2018.4251

Must Reads in Contraception

Intended Pregnancy After Being Denied an Abortion, Contraception; ePub 2018 Sep 20; Upadhyay, et al

VTE risk for continuous cycle oral contraceptives, Li J et al. JAMA Intern Med. 2018 Oct 1. doi:10.1001/jamainternmed.2018.4251

Provider Counseling in Hormonal Contraception, Contraception; ePub 2018 Sep 15; Craig, et al

Effect of Menstrual Bleeding on IUD Discontinuation, Am J Obstet Gynecol; ePub 2018 Aug 28; Hobby, et al

Leukemia risk after maternal contraception use, Hargreave M et al. Lancet Oncol. 2018 Sep 6. doi: 10.1016/S1470-2045(18)30479-0